Beyond Air, Inc. (XAIR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US08862L2025
Beyond Air, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 3.71 m USD | 7.68 m USD |
| Gross profit | -1.66 m USD | 252,000.00 USD |
| Operating income | -44.54 m USD | -29.04 m USD |
| EBIT | -46.17 m USD | -30.82 m USD |
| Net income | -46.63 m USD | -33.25 m USD |
| Diluted EPS – continuing operations | -0.69 USD | -4.01 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beyond Air, Inc.
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
More stocks
- Indaptus Therapeutics, Inc. (INDP)
- Reliance Global Group, Inc. (EZRA)
- CHASE PACKAGING CORP (WHLT)
- Fathom Holdings Inc. (FTHM)
- QHSLab, Inc. (USAQ)
- MacKenzie Realty Capital, Inc. (MKZR)
- Golden Minerals Co (AUMN)
- MAGELLAN COPPER & GOLD Corp (MAGE)
- PharmaCyte Biotech, Inc. (PMCB)
- PATRIOT GOLD CORP (PGOL)
- Polomar Health Services, Inc. (PMHS)
- WEED, INC. (BUDZ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.